Login / Signup

Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.

Jyoti MayadevDmitriy ZamarinWei DengHeather LankesRoisin O'CearbhaillCarol A AghajanianRussell Schilder
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)
NCT03738228.
Keyphrases
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • lymph node
  • study protocol